D23.0 — Other benign neoplasm of skin of lip
ICD-10-CM
Prior Authorization
No Prior Auth Required
Code is covered without prior authorization (high confidence)
Documentation Required
- Legible medical records must reference the patient's complaint or the physician's physical findings when billing with diagnosis L82.0.
- Documentation must support a significant, separately identifiable E/M service when modifier 25 is appended (separate E/M note tied to the visit and not just the procedure).
- Verify applicable procedure and global policy coding via the Medicare Physician Fee Schedule Database (MPFSDB) to determine where the global surgical policy applies.
- For services requiring a referring/ordering physician, the referring/ordering physician's name and NPI must be reported on the claim.
Key Coverage Criteria
- Removal of benign or malignant skin lesions is addressed per the Local Coverage Determination L33445 and related billing/coding guidance.
- Diagnosis code L82.0 (inflamed seborrheic keratosis) may be used when the medical record documents the patient's complaint or the physician's physical findings for the lesion.
- CPT 88182 reports the physician professional and facility technical components of DNA ploidy and S-phase analysis of tumor by flow cytometry.
- CPT 88184 (first marker) and CPT 88185 (each additional marker) report the facility technical component of flow cytometric immunophenotyping for assessment of potential hematolymphoid neoplasia.
- Flow cytometry interpretation is reported using CPT codes 88187–88189 (one interpretation code per specimen).
- Quantitative cell counts by flow cytometry are billed using CPT codes 86355, 86356, 86357, 86359, 86360, 86361, and 86367.
20 Active Policies
L35498 — Removal of Benign Skin Lesions
J05
A57482 — Billing and Coding: Removal of Benign Skin Lesions
J05
L36850 — Peripheral Nerve Blocks
J06
A57452 — Billing and Coding: Peripheral Nerve Blocks
J06
A57113 — Billing and Coding: Removal of Benign Skin Lesions
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.